Benzinga Strategies
Rodman and Renshaw's Benjamin on the DNDN earnings debacle
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:14:07
- Mais informações
Informações:
Sinopse
Rodman and Renshaw senior biotech analyst Dr. Reni Benjamin discusses the causes behind the more than 60% wipeout in Dendreon's market value after their earnings report and how he is tweaking his models going forward.
